BioControl vs C2i Genomics
BioControl vs C2i Genomics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioControl is on 42/100 and C2i Genomics on 62/100.
Where each one leads
BioControl
Leads on none of the measures we hold for both companies.
C2i Genomics
- our overall score: 62/100 against 42/100
- agent readiness: 30/100 against 21/100
- domain rating: 63/100 against 20/100
- funding raised: $112M against $76.0M
At a glance
| Measure | BioControl | C2i Genomics |
|---|---|---|
| What it is | BioControl develops advanced diagnostic solutions for infectious diseases and cancer. | Comprehensive whole-genome monitoring for cancer recurrence and progression. |
| Category | Healthcare, HealthTech, MedTech, Biotech | Healthcare, Genomics, Cancer, Tumor Detection |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 1999 | 2018 |
| Headquarters | Cucamonga, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | BioControl | C2i Genomics |
|---|---|---|
| Employees | Not published | 17 |
| Headcount growthLast 12 months | Not published | -20.8% |
| Total funding | $76.0M | $112M |
| Latest round | Strategic | Series B |
| LinkedIn followers | Not published | 6,366 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioControl | C2i Genomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 62/100 |
| Traction | 39/100 | 53/100 |
| Team | Not published | 90/100 |
| Search visibility | 6/100 | 35/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (30/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioControl | C2i Genomics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
BioControl vs C2i Genomics: common questions
Which is better, BioControl or C2i Genomics?
On our 0-100 score C2i Genomics rates higher (62/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do BioControl and C2i Genomics compare on the numbers?
C2i Genomics leads on our overall score (62/100 against 42/100), agent readiness (30/100 against 21/100), domain rating (63/100 against 20/100), funding raised ($112M against $76.0M).
Read the full BioControl review and pricing or the C2i Genomics review and pricing. You can also browse other BioControl alternatives we track.